Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine with Peg-IFN and Ribavirin in Chronic Hepatitis C
NCT01272310Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hydroxychloroquine in hepatitis C virus infection, sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01272310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01272310.